These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 689280)

  • 1. Immediate post-termination contraception insertion of copper "T" device following menstrual aspiration.
    Rajan R; John R
    J Obstet Gynaecol India; 1978 Feb; 28(1):35-9. PubMed ID: 689280
    [No Abstract]   [Full Text] [Related]  

  • 2. The intrauterine contraceptive device.
    Barwin BN; Tuttle S; Jolly EE
    Can Med Assoc J; 1978 Jan; 118(1):53-8. PubMed ID: 620385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of Lippes Loop and CuT inserted in immediate post-abortal period.
    Chowdhury NN; Mandal GS; Das M
    J Obstet Gynaecol India; 1979 Apr; 29(2):234-44. PubMed ID: 12156558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrauterine device termination rates and the menstrual cycle day of insertion.
    White MK; Ory HW; Rooks JB; Rochat RW
    Obstet Gynecol; 1980 Feb; 55(2):220-4. PubMed ID: 7352085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of menstrual blood loss in Belgian users of the frameless copper-releasing IUD with copper surface area of 200 mm2 and users of a copper-levonorgestrel-releasing intrauterine system.
    Wildemeersch D; Rowe PJ
    Contraception; 2004 Aug; 70(2):169-72. PubMed ID: 15288224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Menstrual blood loss in users of Cu 7 and TCu 220C intrauterine devices].
    Pedrón N; Lozano M; Aznar Ramos R
    Ginecol Obstet Mex; 1983 Jan; 51(309):25-8. PubMed ID: 6681284
    [No Abstract]   [Full Text] [Related]  

  • 9. Immediate postabortion intrauterine contraception in nulliparous adolescents.
    Goldman JA; Dekel A; Reichman J
    Isr J Med Sci; 1979 Jun; 15(6):522-5. PubMed ID: 457386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of side-effects of Cu-T as intra-uterine contraceptive device in post medical termination of pregnancy and interval cases.
    Das CR; Pradhan G
    J Indian Med Assoc; 1995 Oct; 93(10):375-6. PubMed ID: 9053409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability and clinical performance of a copper-containing frameless IUCD in Hong Kong.
    Wong CY; Ng WL; Lo ST; Fan YS
    Contraception; 2005 Jan; 71(1):51-4. PubMed ID: 15639073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study of a cupro-contraceptive intrauterine device (copper 7: Gravigarde)].
    Levrier M
    Gynecologie; 1974; 25(1):35-40. PubMed ID: 4420221
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficiency and acceptability of intrauterine contraceptive devices.
    Trutko NS
    Acta Med Hung; 1986; 43(2):103-8. PubMed ID: 3588154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Early postpartum insertion of copper IUDs].
    Hagbard L; Ingemanson CA; Sorbe B
    Lakartidningen; 1979 Oct; 76(41):3527-9. PubMed ID: 522541
    [No Abstract]   [Full Text] [Related]  

  • 15. [The clinical efficacy of the copper-containing intrauterine devices Nova T and Copper-T-200 Ag in a randomized study (author's transl)].
    Altmann G; Feichtinger W; Havelec L; Beck A
    Wien Klin Wochenschr; 1981 Sep; 93(17):556-8. PubMed ID: 7303702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrauterine devices.
    Mishell DR
    Clin Obstet Gynaecol; 1984 Dec; 11(3):679-700. PubMed ID: 6509856
    [No Abstract]   [Full Text] [Related]  

  • 17. A three-year study of the copper-7 minigravigard intrauterine contraceptive device in nulliparous women.
    Srisupandit S
    J Med Assoc Thai; 1988 Jun; 71(6):294-7. PubMed ID: 3171448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nova-T and Copper-T in a 5 years' comparison].
    Nygren KG; Allonen H; Nielsen NC; Luukainen T; Pyörälä T
    Geburtshilfe Frauenheilkd; 1984 Mar; 44(3):180-4. PubMed ID: 6373482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intrauterine contraception with bioactive devices. Clinico-statistical experience with a copper-potentiated IUD (Gravigard)].
    Foti A; Carluccio A
    Minerva Ginecol; 1979 Sep; 31(9):629-38. PubMed ID: 395462
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of menstrual blood loss in Brazilian users of the frameless copper-releasing IUD with copper surface area of 330 mm2 and the frameless levonorgestrel-releasing intrauterine system.
    Andrade AT; Souza JP; Andrade GN; Rowe PJ; Wildemeersch D
    Contraception; 2004 Aug; 70(2):173-7. PubMed ID: 15288225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.